Patent classifications
C12R2001/385
COMPOSITIONS AND METHODS FOR REMEDIATION OF SULFATE REDUCING PROKARYOTES
Compositions and methods are provided for use in controlling souring and corrosion causing prokaryotes, such as SRP, by treating oil and gas field environments or treatment fluids with a newly identified bacterial strain ATCC Accession No. PTA-124262 as a self-propagating whole cell that produces an anti-SRP bacteriocin in situ. In another aspect, the methods use one or more toxic peptides or proteins isolated therefrom in methods to control unwanted prokaryotic growth in these environments.
PROCESS FOR PRODUCING A RHAMNOLIPID PRODUCED BY PSEUDOMONAS OR ENTEROBACTER USING ANDIROBA OR MURUMURU SEED WASTE
Process for producing a rhamnolipid produced by Pseudomonas or Enterobacter using andiroba or murumuru seed waste, pertaining to the sector of compounds containing monosaccharide radicals, consists of producing rhamnolipids by a biotechnological process using andiroba or murumuru seed waste, following oil extraction, as a substrate for a Pseudomonas aeruginosa, Enterobacter hormaechei or Enterobacter buriae line cultivated in a bioreactor with a non-dispersive aeration system for reducing foam, producing a rhamnolipid content of 10.5 g/L for Pseudomonas aeruginosa bacteria, in bioreactors carried out in a stirred tank with non-dispersive aeration using microporous membranes, particularly of silicone tubes, which allow oxygen to be supplied by diffusion. This type of aeration allows for various configurations, and in the embodiment of the invention, the porous membrane/tube was internally located in the liquid in the bioreactor in the form of a serpentine, under the following process conditions: pure oxygen with suitable pressure and flow rate to maintain O2 pressure in the bioreactor at 20% during the first 24 hours of the assay and stirring varying from 300 to 700 rpm, using 2 radial impellers and manual adjustment according to the decrease in the concentration of dissolved oxygen. The product produced has features that can be used primarily in the cosmetic industry due to its emulsifying, stability and non toxicity capacities.
Live attenuated vaccines
The present invention refers to a method for the production of live attenuated bacterial strains, suitable as vaccine candidates, comprising the steps of: A. providing a bacterial strain capable of expressing glutamate racemase and possibly D-amino acid transaminase and comprising a peptidoglycan cell wail, and B. inactivating the gene or genes encoding for the glutamate racemase enzyme and, if needed, the gene or genes encoding for the enzyme D-amino acid transaminase in such way that the bacterial strain is no longer capable of expressing a functional glutamate racemase and/or a functional D-amino acid transaminase; wherein the inactivation of said genes causes said bacterial strain to be auxotrophic for D-glutamate.
FC Monomer Polypeptide and Application Thereof
Provided is an Fc monomer polypeptide, comprising CH2 and CH3 domains, the Fc monomer polypeptide comprising an amino acid sequence shown in SEQ ID NO: 1; X0 is L or S; X1 is any one amino acid among C, G, S, L, N, D, F, I, V, Y, Q, K, E, M, T or R; X2 is any one amino acid among H, L, Q, N, D, Y, R, C, G, S, F, T, I, V, A, K or M; X3 is any one amino acid among P, N, T, I, S, M, Q, R, L, G, V, A, E, D, Y, F, H or K; X4 is any one amino acid among K, N, S, I, M, E, Q, L, V, A, H, D, Y, F or T; and X5 is M or Y Beneficial effects: a class of IgG Fc monomer polypeptides is obtained, the molecular weight thereof is only half of that of a wild type Fc region, the FcRn binding function of an antibody is reserved, and efficient expression in prokaryotic cells can be achieved.
TRANSFERRIN BINDING ANTIBODIES AND USE THEREOF
The present disclosure provides a method to translocate a molecule across cellular membrane by using a transferrin-binding protein. The transferrin-binding protein is capable of specifically binding to transferrin and not disturbing the interaction between transferrin and transferrin receptor.
Compositions and methods for remediation of sulfate reducing prokaryotes
Compositions and methods are provided for use in controlling souring and corrosion causing prokaryotes, such as SRP, by treating oil and gas field environments or treatment fluids with a newly identified bacterial strain ATCC Accession No. PTA-124262 as a self-propagating whole cell that produces an anti-SRP bacteriocin in situ. In another aspect, the methods use one or more toxic peptides or proteins isolated therefrom in methods to control unwanted prokaryotic growth in these environments.
System for hydrogen production under limited aerobic conditions
The present invention provides a method for fermentative hydrogen production under limited aerobic conditions by utilizing the respiratory interaction between a strictly anaerobic hydrogen producing bacterium, E. harbinense YUAN-3, and a facultative anaerobic bacterium, P. aeruginosa PAO1. The two bacteria are co-cultured to produce hydrogen gas in a culture medium without any anaerobic treatment. Sucrose, lactose or glucose are used as the carbon source for the co-culture which can promote the growth of E. harbinense YUAN-3 and reduce substrate competition between two bacteria. L-cysteine is added to increase the hydrogen yield and the production rate. Using 15 g/L glucose and 5 mmol/L L-cysteine, the invented method achieved the hydrogen production yield of 1.11 mol-hydrogen/mol-glucose.
CELLS AND METHOD FOR PRODUCING RHAMNOLIPIDS USING ALTERNATIVE GLUCOSE TRANSPORTERS
The invention relates to cells which make rhamnolipids and are genetically modified such that they have a decreased activity, compared to the wild type thereof, of an ABC glucose transporter and, compared to the wild type thereof, an increased activity of at least one non-ABC glucose transporter and to a method for producing rhamnolipids using the cells according to the invention.
AMURINS LYSINS, AND LYSIN-ANTIMICROBIAL PEPTIDE (AMP) CONSTRUCTS ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
Disclosed herein are methods of inhibiting the growth, reducing the population, or killing of at least one species of Gram-negative bacteria comprising contacting the bacteria with a composition comprising an effective amount of a Chp peptide, lysin, or lysin-AMP construct or active fragments or variants thereof for a period of time sufficient to inhibit said growth, reduce said population, or kill said at least one species of Gram-negative bacteria. Also disclosed herein are methods of inhibiting a Gram-negative bacteria present in sputum; methods of preventing, disrupting or eradicating a Gram-negative bacterial biofilm; and methods of treating a bacterial infection caused by a Gram-negative bacteria.
ISOLATED PSEUDOMONAS AERUGINOSA BACTERIAL STRAIN, NAMED CSMY-1, DEPOSITED UNDER ACCESSION NUMBER RGM2262, WHICH HAS THE CAPACITY TO DEGRADE POLLUTANTS PRESENT IN THE ENVIRONMENT, IN SOILS OR LIQUID INDUSTRIAL
The invention relates to an isolated bacterial strain of Pseudomonas aeruginosa species, referred to as Pseudomonas aeruginosa CSMY-1, deposited in the Microbial Genetic Resources Bank of the Chilean Collection of Microbial Genetic Resources (CChRGM), under accession number RGM2262, on Aug. 7, 2015, which is a facultative strain that can remove chemical components having characteristics that pollute natural or industrial effluents or soils by degrading compounds. The invention also relates to a method for the pollutant bioremediation of a contaminated environments, comprising: a) adding bacteria Pseudomonas aeruginosa CSMY-1 in the form of a biofilm to said contaminated environment; and b) incubating said bacteria Pseudomonas aeruginosa CSMY-1 in the form of a biofilm in said environment.